Article Text

Download PDFPDF
Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Correction notice This paper has been modified since it was first published online. All references from 57 onwards have been corrected.

  • Competing interests LB declares paid participation to advisory boards or educational activities for Abbott, Ferring Pharmaceuticals and MSD.

  • Provenance and peer review Commissioned; externally peer reviewed.